LILMF

LILMF

Lilium N.
V. is an aerospace company focused on developing all-electric vertical take-off and landing (eVTOL) aircraft for regional air mobility. It aims to position itself as a leader in sustainable air travel by creating a high-speed, zero-emissions transportation network for inter-city travel.

$0.00 -0.00 (-8.00%)

Updated: December 28, 2025, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model ✓ Updated Daily

Investment Opinion: Should I buy LILMF Today?

Based on a comprehensive analysis of LILMF, this stock presents an extremely high-risk profile that makes it unsuitable for investment.

The technical picture is catastrophic, with a near-total loss of value and a price of $0.00 reflecting complete market abandonment. The extreme volatility and maximum drawdown of -99.97% indicate a high probability of permanent capital loss. Fundamentally, the lack of available financial data prevents any proper assessment of the company's health, which is itself a major red flag. The unusual valuation metrics, particularly the negative book value, suggest deeper financial distress that traditional metrics cannot adequately capture.

Recommendation: STRONG SELL. This equity exhibits characteristics of a distressed or defunct company with negligible recovery prospects. The combination of technical collapse, absent fundamental data, and extreme risk metrics makes it untouchable for prudent investors. Capital preservation should take absolute priority, and any funds allocated here would be better described as a speculative gamble than an investment.

CTA Banner

LILMF 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the comprehensive analysis provided, the 12-month outlook for LILMF is exceptionally negative and virtually hopeless.

Key catalysts for any potential recovery are non-existent; the stock appears to be that of a defunct or terminally distressed company, evidenced by its $0.00 price and -99.97% drawdown. The primary potential risk is the absolute and permanent loss of all invested capital, as the complete lack of fundamental data and negative book value signal irreversible financial failure. Given the catastrophic state and lack of analyst coverage, no meaningful target price range can be established, and the only prudent expectation is for the stock to remain worthless.

Wall Street Consensus

Most Wall Street analysts are optimistic about LILMF's 12-month outlook, with consensus target around $0.00, indicating expected upside potential.

Average Target
$0.00
0 analysts
Implied Upside
+0%
vs. current price
Analyst Count
0
covering this stock
Price Range
$0 - $0
Analyst target range
Buy Buy
0 (0%)
Hold Hold
0 (0%)
Sell Sell
0 (0%)

Bulls vs Bears: LILMF Investment Factors

Overall, LILMF has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Cash infusion from patent sale: Generates immediate liquidity by monetizing intellectual property assets.
  • Focus on core development: Allows company to concentrate resources on primary aircraft program.
  • Industry validation of technology: Patent acquisition by competitor acknowledges value of Lilium's innovations.
Bearish Bearish
  • Loss of strategic intellectual property: Selling patents weakens competitive advantage and future revenue potential.
  • Funding concerns persist: Asset sale may indicate ongoing financial pressure and cash burn issues.
  • Competitive strengthening: Directly enhances rival's technology base without clear strategic benefit.
  • Market perception challenges: Could signal desperation or strategic missteps to investors.
Reward Banner

LILMF Technical Analysis

Overall Performance: LILMF has experienced catastrophic declines, effectively rendering the equity worthless with a current price of $0.00 and a near-total 1-year maximum drawdown of -99.97%.

Short-term Performance: The stock's performance over the last one and three months has been disastrous, with declines of 50.0% and 94.2% respectively. It has severely underperformed the broad market, as evidenced by its -98.6% relative strength over three months, and its high beta of 2.318 indicates extreme volatility has greatly amplified these losses.

Current Position: The current price of $0.00 is at the absolute nadir of its 52-week range, which extends from $0.0001 to $0.35. Given the complete price collapse and near-100% drawdown, the stock is in a state of extreme distress that is beyond conventional definitions of oversold.

📊 Beta
2.32
2.32x market volatility
📉 Max Drawdown
-100.0%
Largest decline past year
📈 52-Week Range
$0-$0
Price range past year
💹 Annual Return
-99.2%
Cumulative gain past year
Period LILMF Return S&P 500
1m -54.0% +2.6%
3m -92.3% +4.7%
6m -95.3% +16.8%
1y -99.2% +17.4%
ytd -98.9% +19.5%

LILMF Fundamental Analysis

Based on the limited information available, a comprehensive fundamental analysis of LILMF cannot be conducted. The lack of a recent quarterly report and basic financial ratios severely hinders any substantive evaluation.

Without financial statements, it is impossible to assess the company's revenue trends, profitability, or overall financial health, including its liquidity and leverage. Similarly, key operational efficiency metrics like return on equity or asset turnover cannot be calculated or analyzed.

This absence of fundamental data is a significant concern for any professional analysis and warrants thorough due diligence to obtain the necessary financial disclosures before any investment consideration can be made.

Quarterly Revenue
N/A
Latest Quarter
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A%
Latest Quarter
Free Cash Flow
N/A
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is LILMF Overvalued?

Valuation Level: The stock exhibits unusual valuation metrics with a TTM PE ratio of 0.0357 and a negative PB ratio of -0.043, indicating the company is likely experiencing significant accounting losses or negative equity. While the EV/EBITDA of 0.303 suggests potential undervaluation based on operating performance, these extreme ratios combined with negative book value raise serious concerns about financial stability and the reliability of traditional valuation measures.

Peer Comparison: Without industry average data available for comparison, it's challenging to contextualize these valuation metrics against sector norms. The absence of meaningful peer benchmarks makes it difficult to determine whether these unusual ratios represent exceptional value or fundamental financial distress requiring careful assessment of the company's specific circumstances and prospects.

Current PE
0.0x
Latest Quarter
vs. Historical
N/A
vs. Industry Avg
-99.9%
Industry PE ~45.3×
EV/EBITDA
0.3x
Enterprise Value Multiple

Investment Risk Disclosure

Volatility Risk: LILMF exhibits extreme volatility risk, with a beta of 2.318 indicating it is more than twice as volatile as the broader market. This speculative nature is alarmingly confirmed by a catastrophic one-year maximum drawdown of -99.97%, which signifies a near-total loss of value and represents an exceptionally high risk of capital destruction.

Other Risks: The stock carries significant additional risks, with a substantial short interest of 11.16% suggesting a notable portion of the market holds a bearish outlook on its prospects. This level of short interest, combined with liquidity concerns typical of micro-cap or distressed stocks, can lead to sharp, unpredictable price movements and difficulty executing trades.

FAQs

Is LILMF a good stock to buy?

Bearish. This stock shows catastrophic technical decline (effectively $0.00 price, -99.97% drawdown), extreme volatility (beta 2.318), and fundamental distress signaled by negative book value and unavailable financials. While the patent sale provides temporary cash, it potentially weakens long-term competitive advantage. Suitable only for speculative investors comfortable with near-total loss risk in distressed micro-caps.

Is LILMF stock overvalued or undervalued?

Based on the limited data available, LILMF appears overvalued despite its low earnings multiples. The key valuation metrics—a PE ratio of 0.035 and a negative PB ratio of -0.043—are extreme and unreliable indicators, stemming from severe accounting losses or negative shareholder equity. Without industry averages for context or fundamental data to support future prospects, these metrics point to a fundamentally distressed company rather than a genuine bargain. The negative book value, in particular, suggests the stock may hold little to no intrinsic value.

What are the main risks of holding LILMF?

Based on the provided information, the key risks of holding LILMF are:

1. Capital Destruction Risk: The stock faces a near-certain risk of permanent capital loss, evidenced by its catastrophic -99.97% maximum drawdown and current price of $0.00. 2. Extreme Volatility Risk: With a beta of 2.318, the stock is more than twice as volatile as the market, leading to severe, amplified price declines. 3. Severe Financial Disclosure Risk: A complete lack of available financial statements makes it impossible to assess the company's solvency, viability, or any fundamental value. 4. Liquidity and Sentiment Risk: High short interest (11.16%) and characteristics of a distressed micro-cap stock create the risk of sharp, unpredictable price moves and difficulty trading.

What is the price forecast for LILMF in 2026?

Based on the available information, the forecast for LILMF through 2026 is not viable. The stock's current price of $0.00, negative book value, and complete absence of fundamental data indicate it is likely a defunct or shell company. As such, no realistic target price range can be established, and the primary assumption is that the equity holds no recoverable value. The forecast is highly uncertain, but the most probable outcome is a permanent loss of capital with no identifiable growth drivers for a recovery.